Evidence map›Paper›PMID 35643504›Full record

ArticleMicrobial cell factories2022

Sustainability of in vitro light-dependent NADPH generation by the thylakoid membrane of Synechocystis sp. PCC6803.

Xiaomeng Tong, Eui-Jin Kim, Jeong K Lee

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Xiaomeng TongDepartment of Life Science, Sogang University, Mapo, Shinsu 1, Seoul, 121-742, Korea.
Eui-Jin KimMicrobial Research Department, Nakdonggang National Institute of Biological Resources, Gyeongsangbuk-do, Sangju-si, 37242, Korea. ejkim@nnibr.re.kr.
Jeong K LeeDepartment of Life Science, Sogang University, Mapo, Shinsu 1, Seoul, 121-742, Korea. jgklee@sogang.ac.kr.
Sogang University · KRNational Institute of Biological Resources · KR

Funding

the Nakdonggang National Institute of Biological Resources NNIBR2021021013the National Research Foundation of Korea grants 2019R1A2C2089870the National Research Foundation of Korea grants 2019R1F1A1061639
6 · The paper itself

Abstract

backgroundNADPH is used as a reductant in various biosynthetic reactions. Cell-free bio-systems have gained considerable attention owing to their high energy utilization and time efficiency. Efforts have been made to continuously supply reducing power to the reaction mixture in a cyclical manner. The thylakoid membrane (TM) is a promising molecular energy generator, producing NADPH under light. Thus, TM sustainability is of major relevance for its in vitro utilization.

resultsOver 70% of TMs prepared from Synechocystis sp. PCC6803 existed in a sealed vesicular structure, with the F

conclusionReducing power generated by light energy has to be consumed for TM sustainability. Otherwise, TM can generate singlet oxygen, causing oxidative damage. Thus, TMs should be kept in the dark when not in use. Although NADPH generation activity by TM can be extended via silica encapsulation, further removal of hydrogen peroxide results in an improvement of TM sustainability. Therefore, as long as ROS formation by TM in light is properly handled, it can be used as a promising source of reducing power for in vitro biochemical reactions.

Indexed as

SynechocystisAdenosine TriphosphateNADPProtonsReactive Oxygen SpeciesSinglet OxygenThylakoidsAdenosine TriphosphateNADPProtonsReactive Oxygen SpeciesSinglet OxygenBiosilicificationNoxReducing powerROSSustainabilityThylakoid membrane

Identifiers

PMID35643504
PMCPMC9148488
OpenAlexW4281768756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.